Infant Formula Safety Modernization Act of 2026
Key claim: The Infant Formula Safety Modernization Act of 2026 (HR7867) would update federal infant-formula safety standards and oversight and has been referred to the House Committee on Energy and Commerce.
Abstract
(HR7867 · 119th Congress) Latest action (2026-03-09): Referred to the House Committee on Energy and Commerce.
Why this matters
Infant formula safety oversight has been a focus of federal policy attention since the 2022 Abbott recall and shortage, and modernization proposals aim to strengthen FDA authority over manufacturing standards, inspection, and recall response. At the referral stage this bill signals continued congressional interest but has no immediate impact on what parents pay or what products are available; practical effects would depend on committee markup and enacted statutory text.